These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 572413)

  • 21. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
    Murphy DL; Donnelly CH
    Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554
    [No Abstract]   [Full Text] [Related]  

  • 28. Oxidation of phenylethanolamine and octopamine by type A and type B monoamine oxidase. Effect of substrate concentration.
    Suzuki O; Katsumata Y; Oya M; Matsumoto T
    Biochem Pharmacol; 1979 Aug; 28(15):2327-32. PubMed ID: 387041
    [No Abstract]   [Full Text] [Related]  

  • 29. Human brain monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M; Bevan Jones AB; Pare CM; Nicholson WJ
    Nature; 1972 Mar; 236(5344):225-8. PubMed ID: 4553640
    [No Abstract]   [Full Text] [Related]  

  • 30. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands.
    Lalies MD; Hibell A; Hudson AL; Nutt DJ
    Ann N Y Acad Sci; 1999 Jun; 881():114-7. PubMed ID: 10415906
    [No Abstract]   [Full Text] [Related]  

  • 32. Distribution and inhibition characteristics of human brain monoamine oxidase.
    Owen F; Cross AJ; Lofthouse R; Glover V
    Biochem Pharmacol; 1979 Apr; 28(7):1077-80. PubMed ID: 444264
    [No Abstract]   [Full Text] [Related]  

  • 33. A method for the isolation and determination of 3-methoxytyramine in brain tissue.
    Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):149-58. PubMed ID: 4277335
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of rat pulmonary monoamine oxidase.
    Kung HC; Wilson AG
    Life Sci; 1979 Jan; 24(5):425-31. PubMed ID: 431330
    [No Abstract]   [Full Text] [Related]  

  • 35. Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). II. Comparison of M & B 9302 inhibition with that of iproniazid.
    Hall DW; Logan BW
    Biochem Pharmacol; 1969 Aug; 18(8):1955-9. PubMed ID: 5811628
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
    Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Properties of monoamine oxidases from myocardial mitochondria].
    Krivchenkova RS; Brusova EG
    Vopr Med Khim; 1977; (6):834-40. PubMed ID: 595488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Monoamine tetrazolium reductase of rat heart mitochondria.
    Sen R; Parmar SS; Guha SR
    J Pharm Pharmacol; 1973 Oct; 25(10):835-7. PubMed ID: 4149751
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
    Adachi YU; Watanabe K; Higuchi H; Satoh T; Vizi ES
    Eur J Pharmacol; 2001 Jun; 422(1-3):61-8. PubMed ID: 11430914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tryptamine: potentiation of its hyperthermic effect in rabbits by various monoamine oxidase inhibitors.
    Quock RM
    Pharmacol Res Commun; 1981 Mar; 13(3):281-6. PubMed ID: 6111091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.